deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT04381364

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) (HALT)

Sponsor: Centrallasarettet Västerås

Conditions Covid-19 Pneumonia, Viral Sars-CoV2
Interventions Ciclesonide Inhalation Aerosol
Updated 10 times since 2020 Last updated: Jan 18, 2022 Started: May 29, 2020 Primary completion: Aug 1, 2021 Completion: Jan 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04381364, this PHASE2 trial focuses on Covid-19 and Pneumonia, Viral and remains ongoing. Sponsored by Centrallasarettet Västerås, it has been updated 10 times since 2020, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshotNot Yet Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Jun 2021 · 31 days · monthly snapshotRecruiting~Jun 2021 – ~Mar 2022 · 9 months · monthly snapshotRecruiting~Mar 2022 – ~Feb 2024 · 23 months · monthly snapshotActive Not Recruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Feb 2024 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  5. Mar 2022 — Feb 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

  1. Jun 2021 — Mar 2022 [monthly]

    Recruiting PHASE2

  2. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  3. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE2

  4. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Jun 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centrallasarettet Västerås
  • Danderyd Hospital
  • Karolinska University Hospital
  • Ola Blennow, MD, PhD
Data source: St Goran's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations